Header Logo

Connection

Kathleen Arcaro to Breast Neoplasms

This is a "connection" page, showing publications Kathleen Arcaro has written about Breast Neoplasms.
Connection Strength

4.716
  1. Sturgeon SR, Sibeko L, Balasubramanian R, Arcaro KF. New Moms Wellness Study: the randomized controlled trial study protocol for an intervention study to increase fruit and vegetable intake and lower breast cancer risk through weekly counseling and supplemental fruit and vegetable box delivery in breastfeeding women. BMC Womens Health. 2022 09 24; 22(1):389.
    View in: PubMed
    Score: 0.416
  2. Sturgeon SR, Sela DA, Browne EP, Einson J, Rani A, Halabi M, Kania T, Keezer A, Balasubramanian R, Ziegler RG, Schairer C, Kelsey KT, Arcaro KF. Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1575-1581.
    View in: PubMed
    Score: 0.380
  3. Muse ME, Titus AJ, Salas LA, Wilkins OM, Mullen C, Gregory KJ, Schneider SS, Crisi GM, Jawale RM, Otis CN, Christensen BC, Arcaro KF. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization. Epigenetics. 2020 10; 15(10):1093-1106.
    View in: PubMed
    Score: 0.350
  4. Williams KE, Jawale RM, Schneider SS, Otis CN, Pentecost BT, Arcaro KF. DNA methylation in breast cancers: Differences based on estrogen receptor status and recurrence. J Cell Biochem. 2019 01; 120(1):738-755.
    View in: PubMed
    Score: 0.315
  5. Murphy J, Sherman ME, Browne EP, Caballero AI, Punska EC, Pfeiffer RM, Yang HP, Lee M, Yang H, Gierach GL, Arcaro KF. Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat. 2016 05; 157(1):13-22.
    View in: PubMed
    Score: 0.266
  6. Yang HP, Schneider SS, Chisholm CM, Browne EP, Mahmood S, Gierach GL, Lenington S, Anderton DL, Sherman ME, Arcaro KF. Association of TGF-?2 levels in breast milk with severity of breast biopsy diagnosis. Cancer Causes Control. 2015 Mar; 26(3):345-54.
    View in: PubMed
    Score: 0.244
  7. Schneider SS, Aslebagh R, Ngounou Wetie AG, Sturgeon SR, Darie CC, Arcaro KF. Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics. Adv Exp Med Biol. 2014; 806:399-408.
    View in: PubMed
    Score: 0.227
  8. Williams KE, Anderton DL, Lee MP, Pentecost BT, Arcaro KF. High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines. Epigenetics. 2014 Feb; 9(2):297-307.
    View in: PubMed
    Score: 0.225
  9. Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF. Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics. 2012 Nov; 7(11):1258-67.
    View in: PubMed
    Score: 0.208
  10. Arcaro KF, Browne EP, Qin W, Zhang K, Anderton DL, Sauter ER. Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer. J Hum Lact. 2012 Nov; 28(4):543-6.
    View in: PubMed
    Score: 0.207
  11. Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics. 2011 Dec; 6(12):1425-35.
    View in: PubMed
    Score: 0.196
  12. Arcaro KF, Anderton DL. Potential of using breast milk as a tool to study breast cancer and breast cancer risk. Future Oncol. 2008 Oct; 4(5):595-7.
    View in: PubMed
    Score: 0.158
  13. Gozgit JM, Pentecost BT, Marconi SA, Otis CN, Wu C, Arcaro KF. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol Cancer Res. 2006 Dec; 4(12):905-13.
    View in: PubMed
    Score: 0.139
  14. Carroll JE, Guard HE, March D, Arcaro KF, Huset C, Balasubramanian R, Kontos D, Sturgeon SR. Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women. Cancer Epidemiol Biomarkers Prev. 2025 Aug 01; 34(8):1306-1313.
    View in: PubMed
    Score: 0.127
  15. Whitham D, Bruno P, Haaker N, Arcaro KF, Pentecost BT, Darie CC. Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics. Expert Rev Proteomics. 2024 Jan-Mar; 21(1-3):81-98.
    View in: PubMed
    Score: 0.115
  16. Arcaro KF, Wang J, Otis CN, Zuckerman BM. Beta-galactosidase and alpha-mannosidase inhibit formation of multicellular nodules in breast cancer cell cultures. Anticancer Res. 2004 Jan-Feb; 24(1):139-44.
    View in: PubMed
    Score: 0.114
  17. Aslebagh R, Whitham D, Channaveerappa D, Lowe J, Pentecost BT, Arcaro KF, Darie CC. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk. Electrophoresis. 2023 07; 44(13-14):1097-1113.
    View in: PubMed
    Score: 0.108
  18. Salas LA, Lundgren SN, Browne EP, Punska EC, Anderton DL, Karagas MR, Arcaro KF, Christensen BC. Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer. Hum Mol Genet. 2020 03 13; 29(4):662-673.
    View in: PubMed
    Score: 0.087
  19. Dunphy KA, Black AL, Roberts AL, Sharma A, Li Z, Suresh S, Browne EP, Arcaro KF, Ser-Dolansky J, Bigelow C, Troester MA, Schneider SS, Makari-Judson G, Crisi GM, Jerry DJ. Inter-Individual Variation in Response to Estrogen in Human Breast Explants. J Mammary Gland Biol Neoplasia. 2020 03; 25(1):51-68.
    View in: PubMed
    Score: 0.087
  20. Aslebagh R, Channaveerappa D, Pentecost BT, Arcaro KF, Darie CC. Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery. Adv Exp Med Biol. 2019; 1140:451-467.
    View in: PubMed
    Score: 0.080
  21. Murphy J, Pfeiffer RM, Lynn BCD, Caballero AI, Browne EP, Punska EC, Yang HP, Falk RT, Anderton DL, Gierach GL, Arcaro KF, Sherman ME. Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology. Breast Cancer Res Treat. 2018 Nov; 172(1):209-219.
    View in: PubMed
    Score: 0.078
  22. Aslebagh R, Channaveerappa D, Arcaro KF, Darie CC. Proteomics analysis of human breast milk to assess breast cancer risk. Electrophoresis. 2018 02; 39(4):653-665.
    View in: PubMed
    Score: 0.075
  23. Sturgeon SR, Pilsner JR, Arcaro KF, Ikuma K, Wu H, Kim SM, Chopra-Tandon N, Karpf AR, Ziegler RG, Schairer C, Balasubramanian R, Reckhow DA. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Breast Cancer Res. 2017 Aug 18; 19(1):94.
    View in: PubMed
    Score: 0.073
  24. Brown SB, Hankinson SE, Arcaro KF, Qian J, Reeves KW. Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):158-64.
    View in: PubMed
    Score: 0.065
  25. Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, Willett WC, Schernhammer ES. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II. Am J Epidemiol. 2015 Feb 01; 181(3):155-62.
    View in: PubMed
    Score: 0.061
  26. Sturgeon SR, Arcaro KF, Johnson MA, Balasubramanian R, Zorn M, Jerry DJ, Schneider SS. DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty. Anticancer Res. 2014 Jun; 34(6):2985-90.
    View in: PubMed
    Score: 0.058
  27. Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst. 2013 Feb 06; 105(3):166-74.
    View in: PubMed
    Score: 0.053
  28. Qin W, Zhang K, Kliethermes B, Ruhlen RL, Browne EP, Arcaro KF, Sauter ER. Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy. BMC Cancer. 2012 Mar 21; 12:100.
    View in: PubMed
    Score: 0.050
  29. Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics. 2010 Oct 01; 5(7):645-55.
    View in: PubMed
    Score: 0.045
  30. Yilmaz B, Ssempebwa J, Mackerer CR, Arcaro KF, Carpenter DO. Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells. J Toxicol Environ Health A. 2007 Jul; 70(13):1108-15.
    View in: PubMed
    Score: 0.036
  31. Ssempebwa J, Carpenter D, Yilmaz B, DeCaprio A, O'Hehir D, Arcaro K. Waste crankcase oil: an environmental contaminant with potential to modulate estrogenic responses. J Toxicol Environ Health A. 2004 Jul 23; 67(14):1081-94.
    View in: PubMed
    Score: 0.029
  32. Gozgit JM, Nestor KM, Fasco MJ, Pentecost BT, Arcaro KF. Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells. Toxicol Appl Pharmacol. 2004 Apr 01; 196(1):58-67.
    View in: PubMed
    Score: 0.029
  33. Browne EP, Dinc SE, Punska EC, Agus S, Vitrinel A, Erdag GC, Anderton DL, Arcaro KF, Yilmaz B. Promoter methylation in epithelial-enriched and epithelial-depleted cell populations isolated from breast milk. J Hum Lact. 2014 Nov; 30(4):450-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.